Crescent Biopharma, Inc.
CBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001253689
In the last 90 days, Crescent Biopharma, Inc. insiders filed 1 open-market purchase and 7 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $532.6M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Crescent Biopharma, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +13 vs. Q3 2022
- Shares held
- 27.5M
- +1.56M (+6.0%) vs. Q3 2022
- Total value
- $83.3M
- +$69.0M (+482.2%) vs. Q3 2022
- New holders
- 18
- 8 more added
- Sold out
- 5
- 13 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $532.6M |
| Q1 2026 | 63 | $476.6M |
| Q4 2025 | 58 | $285.9M |
| Q3 2025 | 41 | $134.6M |
| Q2 2025 | 30 | $173.5M |
| Q1 2025 | 35 | $6.46M |
| Q4 2024 | 41 | $7.56M |
| Q3 2024 | 36 | $3.00M |
| Q2 2024 | 35 | $7.20M |
| Q1 2024 | 69 | $110.5M |
| Q4 2023 | 58 | $82.8M |
| Q3 2023 | 49 | $52.1M |
| Q2 2023 | 55 | $61.9M |
| Q1 2023 | 54 | $46.6M |
| Q4 2022 | 48 | $83.3M |
| Q3 2022 | 35 | $14.3M |
| Q2 2022 | 37 | $15.8M |
| Q1 2022 | 44 | $31.2M |
| Q4 2021 | 47 | $42.7M |
| Q3 2021 | 48 | $64.9M |
| Q2 2021 | 58 | $72.5M |
| Q1 2021 | 78 | $110.4M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Crescent Biopharma, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 9,544,262 | $28.9M | 1.22% | 00.0% | Unchanged |
| NEA Management Company, LLC | 8,967,706 | $27.2M | 1.53% | −121,335−1.3% | Reduced |
| Vanguard Group Inc | 2,275,713 | $6.90M | 0.00% | +396,301+21.1% | Added |
| Acadian Asset Management LLC | 1,943,058 | $5.89M | 0.03% | −47,029−2.4% | Reduced |
| Millennium Management LLC | 922,853 | $2.80M | 0.00% | +556,601+152.0% | Added |
| BlackRock Inc. | 758,696 | $2.30M | 0.00% | −7,189−0.9% | Reduced |
| Geode Capital Management, LLC | 405,335 | $1.23M | 0.00% | +46,940+13.1% | Added |
| First Manhattan Co | 314,141 | $951.8K | 0.00% | +314,141 | New |
| Renaissance Technologies LLC | 257,000 | $779.0K | 0.00% | −269,300−51.2% | Reduced |
| Two Sigma Investments, LP | 218,363 | $661.6K | 0.00% | −9,940−4.4% | Reduced |
| Marshall Wace, LLP | 208,941 | $633.1K | 0.00% | +208,941 | New |
| Two Sigma Advisers, LP | 191,800 | $581.2K | 0.00% | −15,100−7.3% | Reduced |
| State Street Corp | 156,565 | $474.4K | 0.00% | +7,600+5.1% | Added |
| Susquehanna International Group, LLP | 133,612 | $404.8K | 0.00% | +133,612 | New |
| Franklin Resources Inc | 120,671 | $365.6K | 0.00% | 00.0% | Unchanged |
| Eversept Partners, LP | 100,579 | $304.8K | 0.03% | 00.0% | Unchanged |
| Northern Trust Corp | 97,652 | $295.9K | 0.00% | −145−0.1% | Reduced |
| Intellectus Partners, LLC | 81,730 | $247.6K | 0.09% | −38,770−32.2% | Reduced |
| Bridgeway Capital Management, LLC | 80,400 | $243.6K | 0.01% | −75,000−48.3% | Reduced |
| Dimensional Fund Advisors LP | 74,278 | $225.0K | 0.00% | +74,278 | New |
| Goldman Sachs Group Inc | 67,671 | $205.0K | 0.00% | +67,671 | New |
| Simplex Trading, LLC | 67,567 | $204.0K | 0.01% | +65,386+2,998.0% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 65,288 | $197.8K | 0.00% | +65,288 | New |
| XTX Topco Ltd | 63,599 | $192.7K | 0.04% | +63,599 | New |
| Citadel Advisors LLC | 50,322 | $152.5K | 0.00% | +50,322 | New |
| Cubist Systematic Strategies, LLC | 48,297 | $146.3K | 0.00% | +48,297 | New |
| Beirne Wealth Consulting Services, LLC | 40,000 | $121.2K | 0.06% | +40,000 | New |
| Ieq Capital, LLC | 38,363 | $116.2K | 0.00% | 00.0% | Unchanged |
| Pura Vida Investments, LLC | 31,615 | $95.8K | 0.02% | +31,615 | New |
| AE Wealth Management LLC | 26,898 | $81.5K | 0.00% | +26,898 | New |
| Bank of New York Mellon Corp | 26,168 | $79.3K | 0.00% | −70−0.3% | Reduced |
| Jane Street Group, LLC | 24,800 | $75.1K | 0.00% | +24,800 | New |
| Charles Schwab Investment Management Inc | 22,361 | $67.8K | 0.00% | +22,361 | New |
| Morgan Stanley | 16,342 | $49.5K | 0.00% | −27,288−62.5% | Reduced |
| Prentiss Smith & Co Inc | 15,120 | $45.8K | 0.04% | +1,120+8.0% | Added |
| Group One Trading, L.P. | 12,834 | $38.9K | 0.00% | +12,834 | New |
| Commonwealth Equity Services, LLC | 10,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| Freedom Wealth Alliance, LLC | 9,452 | $28.6K | 0.04% | +9,452 | New |
| Federated Hermes, Inc. | 4,038 | $12.2K | 0.00% | −1,025−20.2% | Reduced |
| Hartford Financial Management Inc. | 3,500 | $10.6K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,000 | $6.00K | 0.00% | +1,800+900.0% | Added |
| Archer Investment Corp | 1,000 | $3.03K | 0.00% | +1,000 | New |
| Advisor Group Holdings, Inc. | 600 | $2.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 481 | $1.46K | 0.00% | 00.0% | Unchanged |
| Carolinas Wealth Consulting LLC | 395 | $1.20K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 289 | $876 | 0.00% | +7+2.5% | Added |
| Bank of America Corp | 118 | $358 | 0.00% | −9,186−98.7% | Reduced |
| Barclays PLC | 76 | $230 | 0.00% | +76 | New |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −36,630−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −21,577−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −17,262−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −17,600−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |